Report Cover

Global Hospital-Acquired Infection (HAI) Diagnostic Market Growth (Status and Outlook) 2021-2026


According to this latest study, the 2021 growth of Hospital-Acquired Infection (HAI) Diagnostic will have significant change from previous year. By the most conservative estimates of global Hospital-Acquired Infection (HAI) Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hospital-Acquired Infection (HAI) Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection (HAI) Diagnostic market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Molecular Diagnostics
    Blood Tests
    Urinalysis

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Urinary Tract Infections
    Pneumonia
    Surgical Site Infections
    Bloodstream Infections
    Other Hospital Infections

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    bioM?(C)rieux
    Abbott Laboratories
    Alere, Inc.
    Roche
    Siemens Healthcare
    Becton Dickenson
    Cepheid Inc.
    Thermo Fisher Scientific
    Seegene, Inc.
    Qiagen
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2026
        2.1.2 Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Region 2020 VS 2021 VS 2026
    2.2 Hospital-Acquired Infection (HAI) Diagnostic Segment by Type
        2.2.1 Molecular Diagnostics
        2.2.2 Molecular Diagnostics
        2.2.3 Urinalysis
    2.3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
        2.3.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Type
        2.3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021)
    2.4 Hospital-Acquired Infection (HAI) Diagnostic Segment by Application
        2.4.1 Urinary Tract Infections
        2.4.2 Pneumonia
        2.4.3 Surgical Site Infections
        2.4.4 Bloodstream Infections
        2.4.5 Other Hospital Infections
    2.5 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
        2.5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Application
        2.5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021)

3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Players
    3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Players
        3.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2019-2021E)
        3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2019-2021E)
    3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Hospital-Acquired Infection (HAI) Diagnostic by Regions
    4.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions (2016-2021)
    4.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
    4.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
    4.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
    4.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)

5 Americas
    5.1 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
    5.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    5.3 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021)
    6.2 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    6.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic by Country (2016-2021)
    7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic by Region (2016-2021)
    8.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
    8.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
    10.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2021-2026)
        10.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2021-2026)
        10.1.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast
        10.1.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast
        10.1.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast
        10.1.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast
    10.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast by Countries (2021-2026)
        10.2.1 United States Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.2.2 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.2.3 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.2.4 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
    10.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2021-2026)
        10.3.1 China Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.3.2 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.3.3 Korea Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.3.4 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.3.5 India Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.3.6 Australia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
    10.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast by Country (2021-2026)
        10.4.1 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.4.2 France Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.4.3 UK Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.4.4 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.4.5 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
    10.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2021-2026)
        10.5.1 Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.5.2 South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.5.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.5.4 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
        10.5.5 GCC Countries Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
    10.6 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Type (2021-2026)
    10.7 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Application (2021-2026)

11 Key Players Analysis
    11.1 bioM?(C)rieux
        11.1.1 bioM?(C)rieux Company Information
        11.1.2 bioM?(C)rieux Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.1.3 bioM?(C)rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.1.4 bioM?(C)rieux Main Business Overview
        11.1.5 bioM?(C)rieux Latest Developments
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Information
        11.2.2 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.2.4 Abbott Laboratories Main Business Overview
        11.2.5 Abbott Laboratories Latest Developments
    11.3 Alere, Inc.
        11.3.1 Alere, Inc. Company Information
        11.3.2 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.3.4 Alere, Inc. Main Business Overview
        11.3.5 Alere, Inc. Latest Developments
    11.4 Roche
        11.4.1 Roche Company Information
        11.4.2 Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.4.4 Roche Main Business Overview
        11.4.5 Roche Latest Developments
    11.5 Siemens Healthcare
        11.5.1 Siemens Healthcare Company Information
        11.5.2 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.5.4 Siemens Healthcare Main Business Overview
        11.5.5 Siemens Healthcare Latest Developments
    11.6 Becton Dickenson
        11.6.1 Becton Dickenson Company Information
        11.6.2 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.6.4 Becton Dickenson Main Business Overview
        11.6.5 Becton Dickenson Latest Developments
    11.7 Cepheid Inc.
        11.7.1 Cepheid Inc. Company Information
        11.7.2 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.7.4 Cepheid Inc. Main Business Overview
        11.7.5 Cepheid Inc. Latest Developments
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Information
        11.8.2 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.8.4 Thermo Fisher Scientific Main Business Overview
        11.8.5 Thermo Fisher Scientific Latest Developments
    11.9 Seegene, Inc.
        11.9.1 Seegene, Inc. Company Information
        11.9.2 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.9.4 Seegene, Inc. Main Business Overview
        11.9.5 Seegene, Inc. Latest Developments
    11.10 Qiagen
        11.10.1 Qiagen Company Information
        11.10.2 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offered
        11.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
        11.10.4 Qiagen Main Business Overview
        11.10.5 Qiagen Latest Developments

12 Research Findings and Conclusion

List of Tables Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Molecular Diagnostics Table 3. Major Players of Blood Tests Table 4. Major Players of Urinalysis Table 5. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021) Table 8. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021) Table 11. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2019-2021E) Table 13. Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Products Offered Table 14. Hospital-Acquired Infection (HAI) Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Regions 2016-2021 Table 19. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country (2016-2021) Table 21. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021) Table 23. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021) Table 25. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region (2016-2021) Table 27. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021) Table 29. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021) Table 31. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country (2016-2021) Table 33. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021) Table 35. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Hospital-Acquired Infection (HAI) Diagnostic Table 44. Key Application and Potential Industries of Hospital-Acquired Infection (HAI) Diagnostic Table 45. Key Challenges of Hospital-Acquired Infection (HAI) Diagnostic Table 46. Key Trends of Hospital-Acquired Infection (HAI) Diagnostic Table 47. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Application (2021-2026) Table 53. bioM?(C)rieux Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 54. bioM?(C)rieux Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 55. bioM?(C)rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. bioM?(C)rieux Main Business Table 57. bioM?(C)rieux Latest Developments Table 58. Abbott Laboratories Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 59. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 60. Abbott Laboratories Main Business Table 61. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Abbott Laboratories Latest Developments Table 63. Alere, Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 64. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 65. Alere, Inc. Main Business Table 66. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Alere, Inc. Latest Developments Table 68. Roche Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 69. Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 70. Roche Main Business Table 71. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Roche Latest Developments Table 73. Siemens Healthcare Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 74. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 75. Siemens Healthcare Main Business Table 76. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Siemens Healthcare Latest Developments Table 78. Becton Dickenson Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 79. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 80. Becton Dickenson Main Business Table 81. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Becton Dickenson Latest Developments Table 83. Cepheid Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 84. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 85. Cepheid Inc. Main Business Table 86. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Cepheid Inc. Latest Developments Table 88. Thermo Fisher Scientific Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 89. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 90. Thermo Fisher Scientific Main Business Table 91. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Thermo Fisher Scientific Latest Developments Table 93. Seegene, Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 94. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 95. Seegene, Inc. Main Business Table 96. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Seegene, Inc. Latest Developments Table 98. Qiagen Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors Table 99. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offered Table 100. Qiagen Main Business Table 101. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. Qiagen Latest Developments List of Figures Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2020 Figure 7. Hospital-Acquired Infection (HAI) Diagnostic in Urinary Tract Infections Figure 8. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Urinary Tract Infections (2016-2021) & ($ Millions) Figure 9. Hospital-Acquired Infection (HAI) Diagnostic in Pneumonia Figure 10. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Pneumonia (2016-2021) & ($ Millions) Figure 11. Hospital-Acquired Infection (HAI) Diagnostic in Surgical Site Infections Figure 12. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Surgical Site Infections (2016-2021) & ($ Millions) Figure 13. Hospital-Acquired Infection (HAI) Diagnostic in Bloodstream Infections Figure 14. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Bloodstream Infections (2016-2021) & ($ Millions) Figure 15. Hospital-Acquired Infection (HAI) Diagnostic in Other Hospital Infections Figure 16. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Other Hospital Infections (2016-2021) & ($ Millions) Figure 17. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2020 Figure 18. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Player in 2020 Figure 19. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Regions (2016-2021) Figure 20. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2021 ($ Millions) Figure 21. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2021 ($ Millions) Figure 22. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2021 ($ Millions) Figure 23. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2021 ($ Millions) Figure 24. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country in 2020 Figure 25. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2020 Figure 26. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2020 Figure 27. United States Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 28. Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 29. Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 30. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Regions in 2020 Figure 31. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2020 Figure 32. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2020 Figure 33. China Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 34. Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 35. Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 36. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 37. India Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 38. Australia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 39. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country in 2020 Figure 40. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2020 Figure 41. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2020 Figure 42. Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 43. France Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 44. UK Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 45. Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 46. Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 47. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region in 2020 Figure 48. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2020 Figure 49. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2020 Figure 50. Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 51. South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 52. Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 53. Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 54. GCC Country Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 55. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 56. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 57. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 58. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 59. United States Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 60. Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 61. Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 62. Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 63. China Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 64. Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 65. Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 66. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 67. India Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 68. Australia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 69. Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 70. France Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 71. UK Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 72. Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 73. Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 74. Spain Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 75. Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 76. South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 77. Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 78. Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions) Figure 79. GCC Country Hospital-Acquired Infection (HAI) Diagnostic Market Size 2021-2026 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us